Healthtech Startups

CareInsights (formerly Agathos) is a mobile-first platform that delivers personalized peer-comparison insights on clinical metrics directly to physicians via text to drive improvements in care quality and reduce costs. The platform targets healthcare systems and physician leaders seeking to reduce clinical variation and improve patient outcomes.

4 investors

Agenus is a biotechnology company developing cancer immunotherapies, including its lead investigational combination of botensilimab (an anti-CTLA-4 antibody) and balstilimab (a PD-1 inhibitor), known as BOT+BAL. It provides access to these investigational medicines for cancer patients through pathways such as clinical trials, Named Patient Programs, and compassionate-use programs across multiple countries.

4 investors

Agscent develops emissions monitoring and breath analysis systems for detecting greenhouse gases and biological markers. The company offers commercial-grade platforms for environmental monitoring and non-invasive diagnostic analysis across agricultural, animal health, and human health applications.

4 investors

AICure is an AI-powered medication adherence platform for life sciences organizations that uses computer vision and machine learning to verify patient medication adherence and capture real-time behavioral data to improve clinical trial outcomes and patient engagement. The platform serves pharmaceutical companies, clinical trial operators, and healthcare organizations seeking objective insights into medication compliance without wearables or invasive hardware.

4 investors

AIRS Medical develops AI software for radiology centers, including MRI image quality enhancement and longitudinal reporting tools grounded in peer-reviewed research and clinical validation. It serves healthcare providers, imaging center operators, and research institutions across more than 50 countries.

4 investors

Ajax Therapeutics is a biotech company developing Type II JAK2 inhibitors for the treatment of myeloproliferative neoplasms (MPNs), including myelofibrosis, using computational chemistry and structural biology in its drug discovery. Its lead candidate, AJ1-11095, is in a Phase 1 clinical trial for patients who have failed currently available Type I JAK2 inhibitors.

4 investors

Albus Health develops clinically validated monitoring technology that tracks respiratory metrics, heart rate, and cough frequency to support clinical studies. Its team includes clinicians, respiratory and sleep researchers, biomedical engineers, and computer scientists serving the clinical research and medical technology field.

4 investors

Alesta Therapeutics develops therapies for rare diseases, with research focused on genetic diseases and oncology. The biotech company works on early-stage drug development and clinical research.

4 investors

Alkeus Pharma develops therapies for retinal diseases, including inherited and neovascular conditions. The company focuses on gene therapies and other advanced treatment modalities for ophthalmology.

4 investors

Allay Therapeutics develops localized pain management technology designed to deliver several weeks of post-surgical pain relief. The company focuses on supporting patients through recovery following surgery.

4 investors

AllClear ID Health provides patient identity management solutions for healthcare providers using mobile IDs and EHR integrations to eliminate patient record mismatching and enable digital health innovation. The platform delivers identity verification at NIST Level 2 assurance with HIPAA and CCPA compliance.

4 investors

Allermi offers custom prescription nasal sprays combining up to four active ingredients to treat nasal allergies (rhinitis), delivered via online allergist consultations and home delivery. It serves adult allergy sufferers in select US states through a direct-to-consumer telehealth model.

4 investors

Allia Health offers an electronic health record (EHR) platform for behavioral health practices, combining intake, scheduling, documentation, prescribing, and billing in one system. It includes an AI scribe that transcribes visits and drafts structured clinical notes, and serves solo practitioners, group practices, and multi-site providers across the US.

4 investors

Allogene Therapeutics develops allogeneic CAR T cell therapies (AlloCAR T) for blood cancers, solid tumors, and autoimmune diseases, using off-the-shelf manufactured cell products rather than patient-derived autologous approaches. The company aims to expand CAR T treatment access through scalable manufacturing, lower costs, and faster treatment delivery.

4 investors

Aloe Care develops a comprehensive platform for monitoring and coordinating care for independent older adults, addressing safety, communication, and care collaboration among family members and caregivers.

4 investors

Alpaca Health connects families of children with developmental differences to a network of independent ABA (Applied Behavior Analysis) therapy providers for in-home, school, or virtual sessions. The platform handles administrative work like billing and insurance for clinicians so they can focus on clinical care.

4 investors

Hello Alpha (formerly Alpha Medical) is an online telehealth service that connects patients with board-certified providers and licensed primary care providers trained in women's health. It offers whole-person and primary care for everyday medical needs through a virtual process, serving women in the United States.

4 investors

Altay Therapeutics develops small molecule inhibitors targeting transcription factors to treat serious diseases including facioscapulohumeral muscular dystrophy and cancer. The company's pipeline includes oral drug candidates designed as first- or best-in-class therapeutics for oncology and inflammatory conditions.

4 investors

Altira provides AI-powered patient engagement and guidance to healthcare systems, combining clinical expertise with adaptive artificial intelligence to improve health outcomes and reduce unnecessary care utilization. The platform serves clinicians and healthcare organizations delivering value-based care.

4 investors

Altis Labs provides a web-based platform that applies AI models to medical imaging data to generate reproducible predictions and quantifications for clinical trials. It serves biopharma and clinical trial teams, helping them detect treatment effects, inform trial design and go/no-go decisions, and generate evidence for reimbursement.

4 investors

Altris AI develops artificial intelligence software for analyzing optical coherence tomography (OCT) scans in eye care, serving ophthalmologists and optometrists for diagnostic support and patient assessment. The company's platform helps detect retinal conditions and glaucoma risk, and is installed in over 500 optometry centers and clinics globally.

4 investors

AltrixBio develops AJN003, a once-daily oral therapy that forms a temporary, non-systemic coating on the stomach and upper gastrointestinal tract to alter nutrient sensing and trigger metabolic and hormonal responses. The platform targets type 2 diabetes and obesity, with potential applications in oral drug delivery.

4 investors

Amae Health provides in-person, coordinated care for people living with severe mental illness (SMI), combining clinical treatment with a precision medicine platform built on longitudinal, data-driven insights. It works with institutions such as Cedars-Sinai, NewYork-Presbyterian, and Massachusetts General Hospital to improve how SMI is diagnosed and treated.

4 investors

Ambient Clinical develops Sepsis DART, a clinical monitoring platform that integrates with Epic, Cerner, and Meditech to identify sepsis patients and track SEP-1 bundle compliance in real time across care transitions. The system provides automated detection, bundle compliance monitoring, and targeted escalations to improve sepsis management in hospitals.

4 investors